CANCER-FIGHTING SIDEKICK
Harvard researchers discovered a pathway that might offer a new way to fight cancer drug resistance.
Nathaniel Brooks Horwitz is the co-founder and CEO of Nivien Therapeutics.
Harvard researchers discovered a pathway that might offer a new way to fight cancer drug resistance.